GIB-7

GIB-7 is a premium synbiotic functional food developed by GI Longevity (formerly GI Biome) using its proprietary Microbiome+ Herbal Therapy platform. It consists of three patented probiotic strains combined with specific herbal ingredients. GIB-7 is designed to target aging-related conditions by modulating the gut microbiome. Preclinical studies in aging mouse models have shown that GIB-7 increases beneficial gut microbiota, regulates circadian rhythms, and improves muscle strength. Clinical evaluations have demonstrated its potential in enhancing sleep quality in the elderly and improving postoperative quality of life for colorectal cancer patients. It is also being explored in combination with GI-102, an immune-boosting drug, as a comprehensive anti-aging strategy.